Zinodap 10mg Tablet

Clinical studies have demonstrated its efficacy in reducing HbA1c, fasting plasma glucose, and postprandial glucose levels. Additionally, dapagliflozin has shown benefits in reducing body weight and systolic blood pressure, contributing to overall cardiovascular risk reduction. The usual recommended dose is 10mg once daily, taken orally in the morning, with or without food. Common adverse effects include urinary tract infections, genital mycotic infections, and increased urination.

Caution is advised in patients with renal impairment, hypotension, or risk factors for ketoacidosis. Regular monitoring of renal function and glycemic parameters is recommended during therapy. Zinodap should be used under medical supervision with appropriate lifestyle modifications for optimal diabetes management.